Isabella A. Castellano

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 132 publications

Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.

Management of high-risk (B3) breast lesions in symptomatic practice: evidence review and practical recommendations for multidisciplinary care.

Journal: Virchows Archiv : an international journal of pathology

Published: June 19, 2026

Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus.

Integrating PIK3CA Testing into Clinical Practice for Advanced HR+/HER2- Breast Cancer: An Expert Consensus.

Journal: Breast (Edinburgh, Scotland)

Published: February 12, 2026

Lipid Metabolism and Ferroptosis Resistance in Dormant Breast Cancer Cells: Emerging Therapeutic Vulnerabilities.

Lipid Metabolism and Ferroptosis Resistance in Dormant Breast Cancer Cells: Emerging Therapeutic Vulnerabilities.

Journal: Diagnostics (Basel, Switzerland)

Published: January 22, 2026

Histological subtype and receptor characteristics of cancers detected or missed by digital mammography and tomosynthesis: Results from MAITA randomized trials.

Histological subtype and receptor characteristics of cancers detected or missed by digital mammography and tomosynthesis: Results from MAITA randomized trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: October 17, 2025

Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and Pathologists.

Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and Pathologists.

Journal: JCO oncology practice

Published: October 09, 2025

Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project.

Standardizing the pathologic assessment of HER2-(ultra)low breast cancer: insights from a national Italian project.

Journal: Pathologica

Published: July 31, 2025

Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in Immunotherapy.

Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in Immunotherapy.

Journal: Current issues in molecular biology

Published: July 31, 2025

Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.

Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer.

Journal: Pathologica

Published: July 23, 2025

Triple-negative lobular breast cancer: focus on pathology and clinical challenges.

Triple-negative lobular breast cancer: focus on pathology and clinical challenges.

Journal: Human pathology

Published: June 26, 2025

ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex.

ABCC3 Is a Differential Marker of CYP11B2-Negative Zona Glomerulosa Cells in Human Adrenal Cortex.

Journal: Endocrine pathology

Published: April 28, 2025

IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBC.

IL-3/STAT5/miR-155-5p axis supports stem-related pathway reprogramming in TNBC.

Journal: Breast cancer research : BCR

Published: April 21, 2025

Immunohistochemistry for PTEN testing in HR +/HER2- metastatic breast cancer.

Immunohistochemistry for PTEN testing in HR +/HER2- metastatic breast cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: March 24, 2025

Showing 1-12 of 132

Last Updated: 09/26/2026